Should pharmaceutical prices be regulated? The strengths and weaknesses of the British pharmaceutical price regulation scheme

Should pharmaceutical prices be regulated? The strengths and weaknesses of the British pharmaceutical price regulation scheme

Davis, Peter
Identifier: http://hdl.handle.net/2292/20869
Issue Date: 1998
Reference: Health Care Analysis 6(2):168-169 1998
Rights (URI): https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm

Show full item record

Files in this item

There are no files associated with this item.
Icon
DOI: 10.1007/BF02678123
Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics